Figure 1From: Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human gliomaSLC22A18 is downregulated in glioma. Representative images of SLC22A18 immunohistochemical staining in (A) adjacent normal brain tissue and (B) glioma, × 200. (C) Semiquantitative analysis of SLC22A18 expression in glioma and the adjacent brain tissue, P value compares overall SLC22A18 expression in each group.Back to article page